In HNSCC retrospective studies revealed that ctDNA profiling identified actionable alterations in approximately two-thirds of patients, with specific changes in DNA repair genes and TP53 associated with poor overall survival. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.